PQS STEP 7 - Antibiotic AUDIT

Published: Mon, 10/04/21

PharmaPlus PQS Bitesize Guide Step 7:

Antibiotic AUDIT

04 October 2021

Dear Member,

So far we have shared:
STEP 1: Returning unwanted inhalers – Email sent on 31/08/2021
STEP 2: NMS expansion and gateway criteria – Email sent on 1/09/2021

STEP 3: Inhaler technique checks as part of the catch up NMS service – Email sent on 10/09/2021
STEP 4: Staff training requirements – Email sent on 14/09/2021
STEP 5: PCN Leads requirements – Event on 27/09/2021

STEP 6: Infection prevention & control and AMS - Email sent on 27/09/2021

Next is:
STEP 7: TARGET antibiotic checklist audit.

What you need to do:

1.   AUDIT: Over 4 weeks with a minimum of 25 patients – if this is not achieved extend to 8 weeks.
2.   Record your start and end date – Required for your MYS declaration.
3.   Print copies of the target antibiotic checklist – complete 1 per patient prescribed an antibiotic.
4.   Promote antimicrobial stewardship during these discussions to ensure safe and effective use.
5.   When to refer to a prescriber:
      a).   Potential risk of antibiotic related adverse effects (e.g. change in allergy status)
      b).   Concerns about the patients therapy
6.   Patient referrals to a prescriber must be followed up to identify actions taken.
      a).   Record this in the patients PMR as an intervention.
7.   Enter your data onto Public Health England (PHE) portal application. This is MANDATORY.

No patient identifiable data should be entered into the PHE portal application.

As always, if you require any further support please contact the PharmaPlus team.

Regards,

PharmaPlus

Book Your TRAINING

Pre-Reg Training 2021

Pharma Plus Ltd.

Unit B1-B3, Livingstone Court, 55 Peel Road, Harrow, Middlesex HA37QT

info@pharmaplusltd.co.uk | Tel: 020 8863 3335 | Fax: 020 8863 4144 | www.pharmaplusltd.co.uk

Missed an email? Click here for an archive of our most recent communications!

NOTICE

The information contained in this electronic transmission is protected by privilege (which is not waived), strictly confidential and intended for use only by the addressee. If you receive this electronic transmission by mistake then the dissemination distribution or copying of it is strictly prohibited. In such a case please contact us immediately by telephone or return this electronic transmission.